This article was originally published in The Tan Sheet
National Advertising Division of the Council for Better Business Bureaus made four inquiries in 1993 regarding advertising claims for OTC drugs, down from five OTC-related actions in 1992. Three out of the four 1993 cases investigated by NAD stemmed from product efficacy claims. The cases involved McNeil's Tylenol ("The Tan Sheet" May 31, 1993, p. 10), Serendipity Media's Oxygen Cocktail and Oxygen Plus capsules, Livingston Labs' PMS Natural Relief ("The Tan Sheet" Dec. 20, 1993, p. 19) and Ciba's Efidac/24 ("The Tan Sheet" Jan. 17, p. 10)
You may also be interested in...
Perrigo promotes in pricing, planning
Combe sells most of its OTC brands
Finalization of a settlement between the Federal Trade Commission and Rexall Sundown regarding unsupported cellulite treatment claims for the firm's Cellasene dietary supplement hinges upon approval of two related class action settlements pending in California and Florida, according to FTC